Poseida Therapeutics
Read the Press Release: Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies.
View Pipeline: Learn about molecules developed by Genentech (including legacy Poseida programs).
Join the Genentech Team
Be part of the team that’s answering some of the biggest questions in healthcare.
Explore Jobs